- Home
- GOSS vs GCTS Comparison
GOSS vs GCTS Comparison
Compare GOSS & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOSS | GCTS |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.2M | 82.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOSS | GCTS |
|---|---|---|
| Price | $3.13 | $1.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $8.60 | $3.50 |
| AVG Volume (30 Days) | ★ 4.5M | 206.9K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $44,051,000.00 | $3,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.41 | $1,184.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.76 | $0.90 |
| 52 Week High | $3.87 | $2.76 |
Technical Indicators
Market Signals| Indicator | GOSS | GCTS |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 34.30 |
| Support Level | $3.04 | $1.18 |
| Resistance Level | $3.87 | $1.30 |
| Average True Range (ATR) | 0.29 | 0.09 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 11.45 | 12.16 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About GCTS GCT Semiconductor Holding Inc.
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.